RESEARCH
Single-section PMS2/MSH6 double immunohistochemistry shows promise as screening tool for mismatch repair deficiencyA study of 794 colorectal and endometrial cancer cases evaluated whether a single-section test could accurately identify deficient mismatch repair (dMMR) status. (Human Pathology)